Clustering data with hclust algorithm for A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis (Study ST000089)

UHPLC-QTOFMS negative ion mode (Analysis AN000142)
MetaboliteStructureF1F2F3F4F5F6F7
PC (34:1)ME6570690.110.130.030.030.023.733.85
SM (d34:1)ME6572050.090.090.020.02NA3.303.32
PC (34:2)ME6570700.570.670.100.110.052.273.14
PI (38:4)ME6571490.160.200.050.04NA2.382.85
PC (36:2)ME6570730.150.170.040.04NA2.822.87
plasmenyl-PE (38:5)ME6571720.040.030.020.040.042.683.05
PC (36:3)ME6570740.250.29NANANA1.292.59
Cer (d40:1)ME6570510.430.500.030.03NA1.922.22
plasmenyl-PE (36:2)ME6571650.490.600.080.190.201.902.23
PC (32:1)ME6570660.050.05NANANA2.392.22
PE (36:2) BME6571270.070.07NANANA2.202.33
PE (38:4) BME6571330.040.04NANANA2.162.28
PC (32:0)ME6570650.060.07NANANA2.272.27
PE (34:1) BME6571240.030.04NANANA2.302.34
plasmenyl-PE (36:4)ME6571660.030.03NANANA2.302.35
Cer (d36:1)ME6570480.140.18NANANA1.752.48
PI (38:5)ME6571500.120.11NANANA1.702.47
Cer (d34:2)ME6570470.280.32NANANA1.792.10
PC (36:4) BME6570750.270.30NANANA1.692.21
PE (34:2) BME6571250.150.16NANANA2.152.15
Cer (d34:1)ME6570460.170.19NANANA1.912.29
PC (36:1)ME6570720.190.22NANANA1.972.18
Cer (d42:2)ME657055NANA0.010.01NA1.261.44
Cer (d40:2)ME6570520.600.70NANANA1.361.58
Cer (d38:1)ME6570490.410.48NANANA1.472.01
Cer (d41:1)ME6570530.460.53NANANA1.531.82
TG (56:8)ME657276NA2.14NA0.690.72NA1.04
plasmenyl-PE (38:4)ME6571710.290.511.842.222.401.201.31
SM (d42:1)ME6572120.691.510.492.391.930.170.85
SM (d38:1)ME6572070.410.950.863.022.200.241.14
SM (d40:1)ME6572080.431.010.662.731.870.221.19
plasmenyl-PC (34:2)ME6571550.580.760.582.101.800.362.13
plasmenyl-PE (34:1)ME6571620.290.600.682.741.911.011.47
plasmenyl-PE (36:1)ME6571640.340.640.722.571.770.981.50
PE (p-36:4) or PE (o-36:5)ME6571341.070.700.450.650.731.872.16
PE (p-38:4) or PE (o-38:5)ME6571351.060.710.531.071.041.431.71
PC (p-38:4) A or PC (o-38:5) AME6570961.030.610.550.950.961.601.94
PC (p-38:5) or PC (o-38:6)ME6570971.010.540.551.050.961.651.95
PC (p-34:2) or PC (o-34:3)ME6570931.430.450.400.610.781.591.82
PC (p-34:1) or PC (o-34:2) AME6570921.340.650.430.780.851.441.72
PC (p-36:2) or PC (o-36:3)ME6570951.240.610.490.830.901.461.80
plasmenyl-PE (34:2)ME6571630.720.650.511.161.221.421.56
PE (36:1)ME6571261.160.850.601.111.191.081.21
PC (o-32:0)ME6570901.250.760.610.821.021.241.33
PC (p-34:0) or PC (o-34:1)ME6570911.340.810.540.970.971.071.39
PC (p-36:1) or PC (o-36:2)ME6570941.290.710.551.061.091.101.34
TG (54:7) AME6572630.571.390.790.770.850.521.90
TG (55:3)ME6572670.680.780.670.851.580.742.03
TG (50:0)ME6572341.440.721.690.641.320.650.28
TG (52:0)ME6572451.480.701.610.711.380.540.27
TG (53:1)ME6572521.000.441.250.972.110.620.57
TG (54:1)ME6572571.270.341.520.871.950.450.33
TG (56:2)ME6572701.200.331.510.881.900.500.46
TG (58:3)ME6572801.360.421.370.821.680.650.42
TG (58:2)ME6572791.340.411.320.931.630.680.44
TG (60:2)ME6572871.300.391.360.941.670.620.43
TG (60:3)ME6572881.280.361.540.971.660.570.38
TG (56:1)ME6572691.310.421.410.961.740.500.39
TG (58:1)ME6572771.340.441.440.901.680.550.37
TG (58:10)ME6572780.950.681.240.921.111.050.87
TG (58:9)ME6572860.890.591.320.931.251.000.84
TG (51:4)ME6572440.970.641.140.631.561.210.85
TG (52:6)ME6572510.890.691.150.731.421.400.79
TG (49:3)ME6572330.980.821.080.651.391.250.83
TG (50:5)ME6572390.950.831.110.731.421.260.69
TG (48:0)ME6572251.541.001.470.481.070.940.31
TG (46:0)ME6572211.380.861.640.511.140.930.39
TG (46:1)ME6572221.360.821.510.541.061.000.60
TG (48:3)ME6572281.160.811.310.531.231.300.66
TG (50:4)ME6572381.190.701.360.511.201.400.66
TG (44:1)ME6572191.291.071.170.551.170.980.58
TG (46:2)ME6572231.290.941.260.541.231.110.54
TG (50:1)ME6572351.390.651.650.531.161.010.48
TG (48:1)ME6572261.260.641.700.521.171.080.55
TG (49:0)ME6572301.290.661.590.511.221.070.48
TG (54:3)ME6572591.200.551.680.631.231.000.62
TG (54:4)ME6572601.190.591.650.621.151.100.64
TG (54:5)ME6572611.160.531.700.641.181.090.65
TG (48:2)ME6572271.130.631.650.521.071.190.76
TG (52:4)ME6572491.180.491.740.521.161.210.69
TG (50:3)ME6572371.210.641.580.481.161.250.67
TG (52:2)ME6572471.260.531.660.541.171.130.66
TG (50:2)ME6572361.230.621.650.521.101.210.66
TG (52:3)ME6572481.260.571.650.521.121.200.66
TG (58:8)ME6572851.060.361.810.481.311.540.58
TG (56:5)ME6572730.990.371.800.531.361.350.69
TG (58:5)ME6572821.100.481.710.541.331.230.59
TG (62:3)ME6572911.210.421.650.821.330.800.49
TG (54:2)ME6572581.200.381.820.721.500.670.52
TG (58:4) AME6572811.130.361.760.681.490.870.50
TG (58:6)ME6572831.020.411.740.431.691.300.59
TG (58:7)ME6572841.000.271.640.541.821.210.59
TG (52:1)ME6572461.080.571.610.571.390.950.71
TG (49:2)ME6572321.190.641.420.471.371.180.70
TG (54:6)ME6572621.170.571.420.631.391.140.62
TG (53:3)ME6572541.150.491.430.571.531.080.72
TG (53:4)ME6572551.050.461.480.601.531.130.75
TG (56:7)ME6572751.090.401.510.581.571.150.71
TG (51:3)ME6572431.100.501.460.491.461.220.78
TG (52:5)ME6572501.110.521.500.551.441.240.63
TG (51:1)ME6572411.150.411.560.601.780.780.60
TG (56:3)ME6572711.090.331.590.671.840.740.61
TG (49:1)ME6572311.180.541.500.541.610.930.59
TG (53:2)ME6572531.170.431.480.601.630.960.66
TG (56:4)ME6572721.120.411.550.571.670.990.62
TG (51:2)ME6572421.040.411.530.551.661.000.79
TG (56:6)ME6572741.020.321.600.561.761.030.70
PE (36:4)ME6571291.750.561.811.000.54NA1.12
PC-O (34:2) (plasmenyl or plasmanyl)ME6571020.881.341.790.800.84NA0.79
PE (36:5)ME6571311.681.111.880.860.95NA0.37
TG (60:4)ME6572890.800.361.282.281.860.310.60
TG (55:1)ME6572650.810.411.351.831.650.450.88
TG (62:2)ME6572900.860.431.292.081.540.440.79
TG (62:4)ME6572920.840.411.322.071.520.460.80
TG (55:2)ME6572660.770.341.371.481.800.540.97
TG (55:4)ME6572680.640.361.451.301.700.661.32
TG (48:4)ME6572290.771.011.111.301.160.891.18
TG (53:5)ME6572560.690.571.321.291.430.821.33
TG (54:7) BME6572640.780.651.251.431.330.811.08
SM (d18:1/16:1)ME6571970.651.670.361.791.470.051.11
SM (d41:1)ME6572110.571.290.491.681.400.161.07
PE (38:4)ME6571320.451.140.701.970.840.021.53
PS (36:2)ME6571780.621.480.461.581.160.101.37
SM (33:1)ME6571810.581.580.551.541.060.061.27
SM (d18:1/14:0)ME6571950.621.330.451.611.080.061.51
SM (d40:2) AME6572100.531.380.411.641.140.121.61
SM (34:0)ME6571820.481.300.481.691.110.021.74
SM (34:1)ME6571830.481.330.481.751.160.011.55
SM (d18:2/23:0)ME6572000.541.320.511.711.070.041.61
SM (d16:1/20:0)ME6571920.531.360.431.741.420.061.47
SM (d18:1/16:0)ME6571960.571.360.511.791.190.041.39
PC (40:5) AME6570841.591.230.541.290.920.081.36
PC-O (36:3) (plasmenyl or plasmanyl)ME6571060.361.341.210.940.80NA1.16
PC (40:6) BME6570870.770.890.911.101.16NA0.96
PC-O (40:5) (plasmenyl or plasmanyl)ME6571151.161.040.990.960.93NA1.02
PC-O (40:7) A (plasmenyl or plasmanyl)ME6571171.101.030.980.990.93NA1.02
PC (40:4)ME6570831.091.040.890.940.98NA1.07
PC-O (38:3) (plasmenyl or plasmanyl)ME6571091.141.100.890.960.92NA1.03
PC (40:3)ME6570821.221.090.790.951.00NA0.99
PC-O (32:0) (plasmenyl or plasmanyl)ME6570981.091.070.850.970.97NA1.03
PC-O (34:0) (plasmenyl or plasmanyl)ME6571001.131.070.850.980.99NA0.98
PC-O (34:1) (plasmenyl or plasmanyl)ME6571011.071.070.880.991.02NA0.96
PC-O (42:4) (plasmenyl or plasmanyl)ME6571201.081.060.901.010.96NA0.97
SM (34:2)ME6571841.081.130.831.000.96NA0.95
PC-O (36:2) (plasmenyl or plasmanyl)ME6571051.141.100.800.971.03NA0.94
PC-O (38:5) B (plasmenyl or plasmanyl)ME6571121.121.110.800.971.03NA0.95
PC-O (44:5) (plasmenyl or plasmanyl)ME6571221.001.090.880.951.01NA1.03
SM (38:2)ME6571870.941.090.810.970.99NA1.10
PC-O (36:5) (plasmenyl or plasmanyl)ME6571080.941.110.901.030.93NA0.99
SM (36:2)ME6571850.901.120.921.000.98NA0.99
SM (d16:1/20:1)ME6571930.951.120.871.000.99NA0.98
SM (42:1)ME6571901.011.160.821.000.94NA0.98
SM (d44:2)ME6572151.021.140.850.970.93NA1.04
PC-O (34:3) (plasmenyl or plasmanyl)ME6571040.961.210.810.961.02NA0.94
SM (32:1)ME6571801.111.180.730.980.95NA0.98
SM (d18:2/24:1)ME6572011.081.170.790.960.96NA0.98
SM (42:2)ME6571911.071.180.750.960.95NA1.02
SM (d18:2/14:0)ME6571991.071.210.770.960.94NA1.00
SM (40:2)ME6571891.031.210.660.951.00NA1.02
SM (38:1)ME6571861.001.200.720.970.99NA1.00
SM (40:1)ME6571881.021.180.740.990.97NA0.98
PE-O (40:6) (plasmenyl or plasmanyl)ME6571400.930.941.011.101.00NA0.94
PE-O (36:5) (plasmenyl or plasmanyl)ME6571370.961.000.881.081.06NA0.90
PE-O (38:5) (plasmenyl or plasmanyl)ME6571380.900.990.961.111.03NA0.89
PC-O (40:6) (plasmenyl or plasmanyl)ME6571160.960.960.951.071.04NA0.93
PE-O (38:6) (plasmenyl or plasmanyl)ME6571390.940.970.941.081.04NA0.92
plasmenyl-PE (38:1)ME6571681.051.010.881.081.04NA0.87
PC-O (34:2) -B (plasmenyl or plasmanyl)ME6571031.011.030.971.041.02NA0.90
PE (34:0)ME6571231.031.011.021.050.97NA0.91
SM (d18:1/21:0)ME6571981.001.090.941.051.00NA0.87
PC-O (32:1) (plasmenyl or plasmanyl)ME6570991.041.070.941.020.99NA0.91
PC-O (42:5) (plasmenyl or plasmanyl)ME6571211.041.070.921.030.97NA0.94
PC-O (38:5) A (plasmenyl or plasmanyl)ME6571110.981.020.961.010.93NA1.07
PC-O (40:7) B (plasmenyl or plasmanyl)ME6571180.951.001.021.030.90NA1.07
PC-O (38:4) (plasmenyl or plasmanyl)ME6571101.001.021.011.020.89NA1.05
PC-O (40:4) (plasmenyl or plasmanyl)ME6571141.021.031.011.000.90NA1.06
PC (38:7)ME6570811.001.000.871.030.98NA1.04
PC-O (36:4) (plasmenyl or plasmanyl)ME6571070.941.020.911.050.93NA1.06
PC-O (38:6) (plasmenyl or plasmanyl)ME6571131.030.991.071.040.93NA0.99
PC-O (40:8) (plasmenyl or plasmanyl)ME6571190.991.001.101.040.94NA0.95
PC (40:6) AME6570860.970.881.091.040.98NA1.05
PC (40:7)ME6570880.940.901.051.051.02NA1.01
PC (40:8)ME6570890.751.160.851.011.01NA1.01
SM (d18:0/14:0)ME6571940.901.120.760.950.91NA1.22
TG (46:3)ME6572241.071.150.960.721.221.130.66
TG (14:0/14:0/14:0)ME6572161.181.250.970.821.440.660.55
TG (44:2)ME6572201.181.220.880.751.350.920.56
plasmenyl-PE (38:2)ME6571691.641.451.111.461.480.600.75
plasmenyl-PE (38:3)ME6571701.521.461.121.431.410.630.78
plasmenyl-PE (40:4)ME6571741.211.291.341.531.310.630.81
plasmenyl-PE (40:6)ME6571761.351.291.191.331.420.750.79
TG (42:0)ME6572170.911.291.011.231.160.700.78
TG (42:1)ME6572180.911.410.941.381.090.680.84
PC (40:6)ME6570850.821.051.111.321.340.320.76
TG (51:0)ME6572400.910.701.251.211.490.590.82

Factors:

F1Treatment:Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | Time Point:4 hours
F2Treatment:Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | Time Point:4 hours
F3Treatment:Media from Human Adipocytes and SKOV3ip1 OvCa Cells Co-Cultured | Time Point:4 hours
F4Treatment:Media from Human Adipocytes Culturing Only | Time Point:4 hours
F5Treatment:Media from SKOV3ip1 OvCa Cells Culturing Only | Time Point:4 hours
F6Treatment:SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | Time Point:4 hours
F7Treatment:SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | Time Point:4 hours
Data matrix
  logo